Angiogenesis in symptomatic intracranial atherosclerosis: Predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence

  1. Arenillas, J.F.
  2. Álvarez-Sabín, J.
  3. Montaner, J.
  4. Rosell, A.
  5. Molina, C.A.
  6. Rovira, A.
  7. Ribó, M.
  8. Sánchez, E.
  9. Quintana, M.
Revue:
Stroke

ISSN: 0039-2499

Année de publication: 2005

Volumen: 36

Número: 1

Pages: 92-97

Type: Article

DOI: 10.1161/01.STR.0000149617.65372.5D GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus